Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInc&gwth Vct Regulatory News (IGV)

  • There is currently no data for IGV

Dividend Declaration

20 Dec 2011 13:21

The Income & Growth VCT plc (the "Company")

20 December 2011

Interim capital dividend

The Board of The Income & Growth VCT plc is pleased to announce that it has declared a special interim capital dividend of 20 pence per share in respect of the year ending 30 September 2012. The dividend will be paid on 27 January 2012 to Shareholders on the Register on 30 December 2011.

This special dividend is being paid subsequent to the sale of the Company's investment in App-DNA Group Ltd to Citrix Systems Inc in November 2011. This realisation, for an initial consideration of £14.6 million, achieved a gain of £14.4 million on the cost of the investment at 30 September 2011 of £0.2 million.

In addition, approximately £1.8 million of further deferred consideration could be receivable over the next four years, subject to various warranties. The total consideration could therefore equate to a return of approximately 32 times the original investment of £0.5 million. £0.3 million of the original investment was loan stock, which had been repaid earlier this year.

Following this payment, cumulative dividends paid to Shareholders (who originally invested in the `S' Share Fund) will rise to 24.5 pence per share.

Including this dividend, former `O' Fund Shareholders will have received cumulative dividends of 40.65 pence per share in respect of their original investment.

The Directors intend that the Company's Dividend Investment Scheme will apply to this dividend in which case, elections under the Scheme should be received by the Scheme Administrator, Capita Registrars, no later than 10 January 2012. The Company is offering shareholders the opportunity to join the Scheme in respect of this dividend only because of the exceptional size of this dividend. The Chairman will be writing to shareholders shortly with details of this offer.

The dividends are tax free for qualifying shareholders.

The Company expects to be announcing an audited NAV per share as at 30 September 2011 by early January 2012 as part of the Company's annual results.

For further information please contact:

Sarah Penfold at Matrix Private Equity Partners LLP, the Company Secretary on

020 3206 7000

XLON
Date   Source Headline
7th Nov 20221:00 pmRNSDirector/PDMR Shareholding
7th Nov 202212:34 pmRNSIssue of Equity and Total Voting Rights
7th Nov 20227:00 amRNSDirectorate Change
3rd Nov 20227:00 amRNSNet Asset Value(s)
17th Oct 20221:35 pmRNSOffer for Subscription – Update
17th Oct 20221:35 pmRNSOffer for Subscription – Update
17th Oct 20229:00 amRNSOffers for Subscription Now Open for Applications
17th Oct 20229:00 amRNSOffers for Subscription Now Open for Applications
12th Oct 20224:00 pmRNSResult of Meeting
10th Oct 202212:00 pmRNSTransaction in Own Shares
5th Oct 20221:50 pmRNSOffers for Subscription and Issue of Prospectus
26th Sep 20229:03 amRNSTransaction in Own Shares
14th Sep 20225:25 pmRNSInterim Management Statement
14th Sep 20223:00 pmRNSFundraising Update, Circular and General Meetings
26th Aug 20223:34 pmRNSDirector/PDMR Shareholding
26th Aug 20222:45 pmRNSIssue of Equity and Total Voting Rights
23rd Aug 20227:00 amRNSTransaction in Own Shares
15th Aug 20227:00 amRNSIntention To Launch Joint Offers For Subscription
2nd Aug 20227:00 amRNSNet Asset Value(s)
8th Jul 202210:01 amRNSDirector/PDMR Shareholding
8th Jul 202210:00 amRNSIssue of Equity and Total Voting Rights
13th Jun 20222:00 pmRNSRealisation of investment - Media Business Insight
13th Jun 202210:00 amRNSRealisation of investment - Media Business Insight
10th Jun 20224:45 pmRNSTransaction in Own Shares
25th May 202210:00 amRNSHalf-year Report
9th Mar 20224:30 pmRNSDirector/PDMR Shareholding
9th Mar 20222:30 pmRNSIssue of Equity & Total Voting Rights
4th Mar 20221:15 pmRNSNet Asset Value(s)
25th Feb 20223:00 pmRNSInterim Management Statement
23rd Feb 20226:29 pmRNSResult of AGM
25th Jan 20223:15 pmRNSDirector Declaration
21st Jan 202212:05 pmRNSFundraising Update
20th Jan 20221:15 pmRNSPublication of a Prospectus and Circular
7th Jan 202210:05 amRNSDirector/PDMR Shareholding
7th Jan 202210:00 amRNSIssue of Equity and Total Voting Rights
4th Jan 20227:00 amRNSTransaction in Own Shares
20th Dec 20216:02 pmRNSReplacement - Annual Financial Report
20th Dec 20215:30 pmRNSAnnual Financial Report
6th Dec 20215:00 pmRNSDividend Declaration - Correction
6th Dec 20217:00 amRNSDirectorate Change
3rd Dec 20219:00 amRNSRealisation of investment - Vian Marketing Limited
2nd Dec 202110:20 amRNSDividend Declaration
8th Nov 20217:00 amRNSIntention to Launch Joint Offers for Subscription
7th Oct 20213:00 pmRNSRealisation of Proactive Group Holdings Inc
1st Oct 20217:11 amRNSCompletion of change in management arrangements
1st Oct 20217:00 amRNSCompletion of Acquisition
28th Sep 20217:39 amRNSTransaction in Own Shares
16th Sep 20217:00 amRNSInterim Management Statement - 3rd Quarter
10th Sep 20217:06 amRNSProposed change in management arrangements
10th Sep 20217:00 amRNSAcquisition and proposed placing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.